Kramp, L.-J.
Mathiak, M.
Behrens, H.-M.
Schäfer, F. W.
van Mackelenbergh, M.
Röcken, Christoph https://orcid.org/0000-0002-6989-8002
Funding for this research was provided by:
Christian-Albrechts-Universität zu Kiel
Article History
Received: 7 July 2021
Accepted: 18 October 2021
First Online: 27 October 2021
Declarations
:
: M. van Mackelenbergh declares to have the following conflicts of interest: Personal Fees, Honoraria or Travel grants from Amgen, AstraZeneca, Daichii Sankyo, GenomicHealth, Lilly, Mylan, Novartis, Pfizer, PierreFabre, Roche and Seagen. All remaining authors have declared no conflicts of interest.